Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration

Baoying Liu, Lai Wei, Catherine Meyerle, Jingsheng Tuo, H. Nida Sen, Zhiyu Li, Sagarika Chakrabarty, Elvira Agron, Chi Chao Chan, Michael Klein, Emily Chew, Frederick Ferris, Robert B. Nussenblatt

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Background: Age related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide. Inflammation, among many factors, has been suggested to play an important role in AMD pathogenesis. Recent studies have demonstrated a strong genetic association between AMD and complement factor H (CFH), the down-regulatory factor of complement activation. Elevated levels of complement activating molecules including complement component 5a (C5a) have been found in the serum of AMD patients. Our aim is to study whether C5a can impact human T cells and its implication in AMD.Methods: Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of exudative form of AMD patients using a Ficoll gradient centrifugation protocol. Intracellular staining and enzyme-linked immunosorbent assays were used to measure protein expression. Apoptotic cells were detected by staining of cells with the annexin-V and TUNEL technology and analyzed by a FACS Caliber flow cytometer. SNP genotyping was analyzed by TaqMan genotyping assay using the Real-time PCR system 7500.Results: We show that C5a promotes interleukin (IL)-22 and IL-17 expression by human CD4+ T cells. This effect is dependent on B7, IL-1β and IL-6 expression from monocytes. We have also found that C5a could protect human CD4+ cells from undergoing apoptosis. Importantly, consistent with a role of C5a in promoting IL-22 and IL-17 expression, significant elevation in IL-22 and IL-17 levels was found in AMD patients as compared to non-AMD controls.Conclusions: Our results support the notion that C5a may be one of the factors contributing to the elevated serum IL-22 and IL-17 levels in AMD patients. The possible involvement of IL-22 and IL-17 in the inflammation that contributes to AMD may herald a new approach to treat AMD.

Original languageEnglish (US)
Article number111
JournalJournal of Translational Medicine
Volume9
Issue number1
DOIs
StatePublished - Jul 15 2011

Fingerprint

T-cells
Interleukin-17
Macular Degeneration
T-Lymphocytes
Assays
Blood
Complement C5a
Complement Factor H
Ficoll
Immunosorbents
Centrifugation
Annexin A5
Real time systems
Interleukin-1
Interleukin-6
Chemical activation
Cells
interleukin-22
Association reactions
Apoptosis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration. / Liu, Baoying; Wei, Lai; Meyerle, Catherine; Tuo, Jingsheng; Sen, H. Nida; Li, Zhiyu; Chakrabarty, Sagarika; Agron, Elvira; Chan, Chi Chao; Klein, Michael; Chew, Emily; Ferris, Frederick; Nussenblatt, Robert B.

In: Journal of Translational Medicine, Vol. 9, No. 1, 111, 15.07.2011.

Research output: Contribution to journalArticle

Liu, B, Wei, L, Meyerle, C, Tuo, J, Sen, HN, Li, Z, Chakrabarty, S, Agron, E, Chan, CC, Klein, M, Chew, E, Ferris, F & Nussenblatt, RB 2011, 'Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration', Journal of Translational Medicine, vol. 9, no. 1, 111. https://doi.org/10.1186/1479-5876-9-111
Liu, Baoying ; Wei, Lai ; Meyerle, Catherine ; Tuo, Jingsheng ; Sen, H. Nida ; Li, Zhiyu ; Chakrabarty, Sagarika ; Agron, Elvira ; Chan, Chi Chao ; Klein, Michael ; Chew, Emily ; Ferris, Frederick ; Nussenblatt, Robert B. / Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration. In: Journal of Translational Medicine. 2011 ; Vol. 9, No. 1.
@article{e13b5bba2a0848a482de66e4cdc02db2,
title = "Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration",
abstract = "Background: Age related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide. Inflammation, among many factors, has been suggested to play an important role in AMD pathogenesis. Recent studies have demonstrated a strong genetic association between AMD and complement factor H (CFH), the down-regulatory factor of complement activation. Elevated levels of complement activating molecules including complement component 5a (C5a) have been found in the serum of AMD patients. Our aim is to study whether C5a can impact human T cells and its implication in AMD.Methods: Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of exudative form of AMD patients using a Ficoll gradient centrifugation protocol. Intracellular staining and enzyme-linked immunosorbent assays were used to measure protein expression. Apoptotic cells were detected by staining of cells with the annexin-V and TUNEL technology and analyzed by a FACS Caliber flow cytometer. SNP genotyping was analyzed by TaqMan genotyping assay using the Real-time PCR system 7500.Results: We show that C5a promotes interleukin (IL)-22 and IL-17 expression by human CD4+ T cells. This effect is dependent on B7, IL-1β and IL-6 expression from monocytes. We have also found that C5a could protect human CD4+ cells from undergoing apoptosis. Importantly, consistent with a role of C5a in promoting IL-22 and IL-17 expression, significant elevation in IL-22 and IL-17 levels was found in AMD patients as compared to non-AMD controls.Conclusions: Our results support the notion that C5a may be one of the factors contributing to the elevated serum IL-22 and IL-17 levels in AMD patients. The possible involvement of IL-22 and IL-17 in the inflammation that contributes to AMD may herald a new approach to treat AMD.",
author = "Baoying Liu and Lai Wei and Catherine Meyerle and Jingsheng Tuo and Sen, {H. Nida} and Zhiyu Li and Sagarika Chakrabarty and Elvira Agron and Chan, {Chi Chao} and Michael Klein and Emily Chew and Frederick Ferris and Nussenblatt, {Robert B.}",
year = "2011",
month = "7",
day = "15",
doi = "10.1186/1479-5876-9-111",
language = "English (US)",
volume = "9",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration

AU - Liu, Baoying

AU - Wei, Lai

AU - Meyerle, Catherine

AU - Tuo, Jingsheng

AU - Sen, H. Nida

AU - Li, Zhiyu

AU - Chakrabarty, Sagarika

AU - Agron, Elvira

AU - Chan, Chi Chao

AU - Klein, Michael

AU - Chew, Emily

AU - Ferris, Frederick

AU - Nussenblatt, Robert B.

PY - 2011/7/15

Y1 - 2011/7/15

N2 - Background: Age related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide. Inflammation, among many factors, has been suggested to play an important role in AMD pathogenesis. Recent studies have demonstrated a strong genetic association between AMD and complement factor H (CFH), the down-regulatory factor of complement activation. Elevated levels of complement activating molecules including complement component 5a (C5a) have been found in the serum of AMD patients. Our aim is to study whether C5a can impact human T cells and its implication in AMD.Methods: Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of exudative form of AMD patients using a Ficoll gradient centrifugation protocol. Intracellular staining and enzyme-linked immunosorbent assays were used to measure protein expression. Apoptotic cells were detected by staining of cells with the annexin-V and TUNEL technology and analyzed by a FACS Caliber flow cytometer. SNP genotyping was analyzed by TaqMan genotyping assay using the Real-time PCR system 7500.Results: We show that C5a promotes interleukin (IL)-22 and IL-17 expression by human CD4+ T cells. This effect is dependent on B7, IL-1β and IL-6 expression from monocytes. We have also found that C5a could protect human CD4+ cells from undergoing apoptosis. Importantly, consistent with a role of C5a in promoting IL-22 and IL-17 expression, significant elevation in IL-22 and IL-17 levels was found in AMD patients as compared to non-AMD controls.Conclusions: Our results support the notion that C5a may be one of the factors contributing to the elevated serum IL-22 and IL-17 levels in AMD patients. The possible involvement of IL-22 and IL-17 in the inflammation that contributes to AMD may herald a new approach to treat AMD.

AB - Background: Age related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide. Inflammation, among many factors, has been suggested to play an important role in AMD pathogenesis. Recent studies have demonstrated a strong genetic association between AMD and complement factor H (CFH), the down-regulatory factor of complement activation. Elevated levels of complement activating molecules including complement component 5a (C5a) have been found in the serum of AMD patients. Our aim is to study whether C5a can impact human T cells and its implication in AMD.Methods: Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of exudative form of AMD patients using a Ficoll gradient centrifugation protocol. Intracellular staining and enzyme-linked immunosorbent assays were used to measure protein expression. Apoptotic cells were detected by staining of cells with the annexin-V and TUNEL technology and analyzed by a FACS Caliber flow cytometer. SNP genotyping was analyzed by TaqMan genotyping assay using the Real-time PCR system 7500.Results: We show that C5a promotes interleukin (IL)-22 and IL-17 expression by human CD4+ T cells. This effect is dependent on B7, IL-1β and IL-6 expression from monocytes. We have also found that C5a could protect human CD4+ cells from undergoing apoptosis. Importantly, consistent with a role of C5a in promoting IL-22 and IL-17 expression, significant elevation in IL-22 and IL-17 levels was found in AMD patients as compared to non-AMD controls.Conclusions: Our results support the notion that C5a may be one of the factors contributing to the elevated serum IL-22 and IL-17 levels in AMD patients. The possible involvement of IL-22 and IL-17 in the inflammation that contributes to AMD may herald a new approach to treat AMD.

UR - http://www.scopus.com/inward/record.url?scp=79960559299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960559299&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-9-111

DO - 10.1186/1479-5876-9-111

M3 - Article

C2 - 21762495

AN - SCOPUS:79960559299

VL - 9

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 111

ER -